“…or I2, pyridine, 42% (19a) ; (c) Pd(PPh3)2Cl2 5%, CuI 10%, Et3N, THF, 50°C, 10-46 % Since the most active compound was the imidazopyridine 20c, we decided to add various substituents to the imidazopyridine moiety in order to evaluate which positions most affect activity. This was achieved from the corresponding commercially available substituted amino pyridines 21a-h which were subjected to the previous cyclization-iodination sequence to provide 23a-h 43,44,45,46,47,48,49 followed by Sonogashira cross-coupling to afford compounds 24a-h (Scheme 4, see Supplementary data for full details). Compound 29 (Scheme 5), bearing a 7-azaindole ring system was prepared by a sequence of transformations including iodination of the commercially available 7-azaindole with N-iodosuccinimide, protection with benzenesulfonyl chloride, Sonogashira reaction with the alkene 15a, and finally deprotection with TBAF in THF.…”